| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 52.713 | 57.858 | 77.789 | 38.476 | 187.297 | 89.558 | 106.230 | 122.681 | 162.090 | 182.478 |
| Total Income - EUR | 61.181 | 72.740 | 113.339 | 90.985 | 423.386 | 106.998 | 116.253 | 155.554 | 184.320 | 224.083 |
| Total Expenses - EUR | 18.029 | 18.836 | 20.744 | 28.239 | 105.488 | 49.917 | 66.058 | 78.817 | 117.010 | 129.600 |
| Gross Profit/Loss - EUR | 43.152 | 53.904 | 92.595 | 62.745 | 317.899 | 57.081 | 50.195 | 76.736 | 67.310 | 94.483 |
| Net Profit/Loss - EUR | 41.317 | 52.449 | 88.530 | 61.835 | 313.665 | 56.103 | 49.057 | 75.534 | 65.744 | 78.541 |
| Employees | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Endovascular S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.255 | 1.033 | 686 | 18.484 | 15.777 | 10.058 | 66.443 | 45.796 | 25.014 | 5.068 |
| Current Assets | 43.733 | 104.187 | 167.362 | 133.351 | 296.713 | 73.814 | 19.060 | 60.978 | 105.236 | 125.781 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.579 | 0 |
| Receivables | 41.669 | 101.480 | 165.103 | 129.672 | 148.419 | 737 | 8.079 | 37.012 | 56.096 | 89.048 |
| Cash | 2.064 | 2.707 | 2.260 | 3.679 | 148.294 | 73.078 | 10.981 | 3.688 | 2.074 | 6.578 |
| Shareholders Funds | 41.371 | 52.502 | 88.583 | 61.887 | 313.715 | 80.634 | 49.105 | 75.583 | 97.017 | 109.462 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.743 | 52.718 | 79.594 | 90.063 | 910 | 3.356 | 48.041 | 37.775 | 33.778 | 21.684 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Endovascular S.r.l.